CD8+, HLA-unrestricted, cytotoxic T-lymphocyte line against malignant melanoma

[1]  F. Marincola,et al.  Inhibition of cytolytic T lymphocyte proliferation by autologous CD4+/CD25+ regulatory T cells in a colorectal carcinoma patient is mediated by transforming growth factor-beta. , 2002, Cancer research.

[2]  P. Robbins,et al.  A listing of human tumor antigens recognized by T cells , 2001, Cancer Immunology, Immunotherapy.

[3]  F. Marincola,et al.  CD4+, HLA class I‐restricted, cytolytic T‐lymphocyte clone against primary malignant melanoma cells , 2000, International journal of cancer.

[4]  G. Parmiani,et al.  T-cell recognition of melanoma-associated antigens. , 2000, Journal of cellular physiology.

[5]  B. Palsson,et al.  Human Cell Culture , 1999, Human Cell Culture.

[6]  G. Trinchieri,et al.  Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus. , 1998, Arthritis and rheumatism.

[7]  F. Marincola,et al.  Cytotoxic T-cell clone against rectal carcinoma induced by stimulation of a patient's peripheral blood mononuclear cells with autologous cultured tumor cells. , 1997, International journal of cancer.

[8]  T. Saida,et al.  Dual recognition of a human cytotoxic T-cell clone for melanoma antigens. , 1996, Cancer research.

[9]  T. Irimura,et al.  Cytotoxic T cells from ovarian malignant tumors can recognize polymorphic epithelial mucin core peptides. , 1993, Journal of immunology.

[10]  K. Jerome,et al.  Tumor-specific cytotoxic T cell clones from patients with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin complementary DNA. , 1993, Journal of immunology.

[11]  D. Elder,et al.  Growth and invasion of human melanomas in human skin grafted to immunodeficient mice. , 1993, The American journal of pathology.

[12]  M. Lan,et al.  Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[13]  N. Chakraborty,et al.  Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma , 1989, The Journal of experimental medicine.

[14]  S. Rosenberg,et al.  Tumor-specific cytolysis by lymphocytes infiltrating human melanomas. , 1989, Journal of immunology.

[15]  M. Herlyn,et al.  Melanoma antigens: immunological and biological characterization and clinical significance. , 1988, Annual review of immunology.

[16]  A. Anichini,et al.  Melanoma cell lysis by human CTL clones: Differential involvement of T3, T8 and HLA antigens , 1987, International journal of cancer.

[17]  J. D. de Vries,et al.  Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity. , 1984, Journal of immunology.